Wealthfront Advisers LLC Buys 959 Shares of Henry Schein, Inc. $HSIC

Wealthfront Advisers LLC grew its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 8.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,956 shares of the company’s stock after purchasing an additional 959 shares during the period. Wealthfront Advisers LLC’s holdings in Henry Schein were worth $873,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of HSIC. Burgundy Asset Management Ltd. grew its stake in shares of Henry Schein by 33.9% in the 1st quarter. Burgundy Asset Management Ltd. now owns 2,235,429 shares of the company’s stock valued at $153,105,000 after purchasing an additional 566,530 shares during the period. Jones Financial Companies Lllp grew its position in Henry Schein by 24,351.3% during the 1st quarter. Jones Financial Companies Lllp now owns 542,330 shares of the company’s stock worth $37,144,000 after acquiring an additional 540,112 shares during the last quarter. JPMorgan Chase & Co. grew its position in Henry Schein by 6.5% during the 1st quarter. JPMorgan Chase & Co. now owns 6,373,036 shares of the company’s stock worth $436,489,000 after acquiring an additional 390,399 shares during the last quarter. Nuveen LLC bought a new stake in Henry Schein during the 1st quarter worth approximately $20,857,000. Finally, Hawk Ridge Capital Management LP bought a new stake in Henry Schein during the 1st quarter worth approximately $19,684,000. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Stock Up 0.5%

NASDAQ:HSIC opened at $63.20 on Friday. The stock’s fifty day moving average price is $66.19 and its two-hundred day moving average price is $68.50. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The company has a market cap of $7.66 billion, a price-to-earnings ratio of 20.39, a P/E/G ratio of 2.06 and a beta of 0.81.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.09). The company had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The business’s revenue for the quarter was up 3.3% compared to the same quarter last year. During the same period last year, the company earned $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current year.

Wall Street Analyst Weigh In

HSIC has been the topic of a number of research analyst reports. Robert W. Baird restated a “neutral” rating and set a $72.00 price target (down from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Weiss Ratings restated a “hold (c-)” rating on shares of Henry Schein in a research report on Friday. UBS Group decreased their price target on Henry Schein from $75.00 to $70.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 6th. Leerink Partners set a $75.00 price target on Henry Schein in a research report on Monday, July 14th. Finally, Baird R W lowered Henry Schein from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 14th. Five research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $76.67.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.